Inkhabar webdesk

By Abhijith Ganapavaram NEW DELHI (Reuters) -India's air safety regulator has sought more information from Boeing Co after an emergency power system was activated on an Air India 787 Dreamliner on Saturday, a government source with direct knowledge of the matter said. Boeing and Air India spokespersons did not immediately respond to requests for comment. The crew of the aircraft – which was flying from the northern Indian city of Amritsar to Birmingham, UK – detected deployment of the power system, known as the Ram Air Turbine, during the final approach, Air India said on Sunday. In July, Indian investigators said the RAT had been deployed during the initial climb before the Air India Boeing 787 crash which killed 260 people the previous month. A preliminary report by Indian investigators showed the plane's fuel engine switches had almost simultaneously flipped from run to cutoff just after takeoff. (Reporting by Abhijith Ganapavaram; Editing by Aditya Kalra, Kirsten Donovan)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

By Maggie Fick and Soren Jeppesen LONDON/COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk has laid off dozens of employees at the largest U.S. manufacturing site for its blockbuster obesity and diabetes drugs, a Reuters review of LinkedIn posts showed, a signal of where it is making cuts in a major restructuring under new CEO Mike Doustdar. The previously unreported cuts included staff in manufacturing roles, from quality control to production line technicians, at Novo's major Clayton, North Carolina, plant and other facilities in the state, an analysis of 73 posts and profiles show. The layoffs, while only a small part of a planned 9,000 job cuts globally, underscore how Novo is cutting back even on frontline production in the top market for Wegovy as it looks to sharpen its focus, trim costs, and claw back lost ground in fierce competition with rival Eli Lilly. The cuts, which follow earlier ones focused on the obesity education team in the U.S., come as the administration of President Donald Trump pressures pharmaceutical companies to expand U.S. drug production and create more domestic jobs. The Danish drugmaker last year became Europe's most valuable listed company on unprecedented demand for weight-loss drugs before a sharp share price slide as sales growth slowed. It is now trying to turn around its fortunes and reduce costs and staff that bloated as it rode the Wegovy boom. A Novo spokesperson declined a Reuters request for further details beyond last month's global layoffs announcement. "This process takes time and our highest priority is to support our employees," the spokesperson said. PLANT MAKES WEGOVY, OZEMPIC The announced wider cuts helped boost Novo's shares, though the company has provided little detail about its plans. It said around 5,000 jobs would be cut in its native Denmark. The North Carolina cuts hit technical manufacturing workers, project coordinators, a strategic communications manager and an HR assistant, the posts revealed. Of the total, 47 directly posted they were looking for work or had been laid off. Novo's Clayton facility makes semaglutide, the active ingredient in Wegovy and diabetes drug Ozempic. It also does manufacturing steps including filling, finishing and packaging the injections. It also will play a key role in producing the new pill version of Wegovy once that becomes available. CEO Doustdar this month heralded an ongoing $4.1 billion expansion at the North Carolina plant that employed some 2,500 people in 2024 and was expected to add 1,000 more. Reuters could not determine the exact number or the reason for the layoffs in Clayton, which came three weeks after Doustdar announced the broader restructuring. Reuters contacted about 30 of the Novo employees who posted on LinkedIn that they had been laid off. One replied, saying a non-disclosure agreement prevented them from speaking to the media. (Reporting by Maggie Fick in London and Soren Jeppesen in Copenhagen; Editing by Adam Jourdan and Bill Berkrot)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

(Corrects dateline to Oct 7, not Oct 6. No change to text) By America Hernandez and Stephanie Kelly PARIS/LONDON -The five biggest global oil majors are moving to cut costs, jobs and share buybacks as falling oil prices threaten to make shareholder payouts unsustainable without increasing debt, analysts said.  Chevron, ExxonMobil, BP, Shell and TotalEnergies have pledged high returns for the past decade to avert an investor exodus as fossil fuels lost their appeal. But maintaining those generous payouts, which have topped $100 million annually since 2022, has increasingly been funded by debt as energy prices retreated from highs caused by sanctions and supply disruptions in the wake of Russia's invasion of Ukraine.  Oil majors, now pressed to reinvest in exploration and production, must choose between cutting some operations, letting debt rise to unsustainable levels or weaning shareholders off popular but pricey returns.  Rising global oil output, meanwhile, is expected to keep prices falling, leaving the majors facing some difficult decisions. Most oil majors need oil prices above $80 a barrel to sustain current levels of dividends and share buybacks, which hit record highs buoyed by bumper profits in 2022, according to data from RBC Capital Markets and BofA Global Research. But Brent oil prices fell below $65 last week, the lowest since July, on fears of oversupply. Citi expects oil prices to drop to the low $60s and Goldman Sachs to the $50s next year. To contend with lower prices, TotalEnergies said it will reduce its buybacks from the fourth quarter of this year and cut costs to the tune of $7.5 billion by the end of 2030 to reduce debt. BP and Chevron have reduced buybacks this year. Shell has not announced plans for any cuts to its buyback programme. More than a dozen energy companies have announced job cuts for 2025 and 2026, including ExxonMobil, Chevron, Shell and BP. ​ (Reporting by America Hernandez in ParisAdditional reporting by Stephanie Kelly in LondonEditing by David Goodman)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)